A prometastatic splicing program regulated by SNRPA1 interactions with structured RNA elements

Nom de la revue
Lisa Fish, Matvei Khoroshkin, Albertas Navickas, Kristle Garcia, Bruce Culbertson, Benjamin Hänisch, Steven Zhang, Hoang C. B. Nguyen, Larisa M. Soto, Maria Dermit, Faraz K. Mardakheh, Henrik Molina, Claudio Alarcón, Hamed S. Najafabadi, Hani Goodarzi

Characterizing a cancer spliceosome

Cells undergo many genomic changes as they progress toward metastatic cancer. One aspect of this change is to RNA expression and splicing isoforms, but how these differences affect tumor progression is not well characterized. Fish
et al.
developed a computational framework called pyTEISER that identifies structural cis-regulatory elements that control diverse types of RNA regulation. Applying pyTEISER to models of breast cancer metastasis, they discovered an RNA short-stem-loop element that forms a “structural splicing enhancer” that acts in cis to regulate alternative splicing of RNA transcripts. One of these interactions encompasses the RNA-binding protein SNRPA1 and results in alternative exon inclusion that affects metastatic capacity in xenograft models. Thus, RNA element binding may play a role in splicing regulation and is potentially an important component of the cis-splicing code.

, this issue p.